Literature DB >> 21277384

When pigs fly: immunomagnetic separation facilitates rapid determination of Pig-a mutant frequency by flow cytometric analysis.

Stephen D Dertinger1, Steven M Bryce, Souk Phonethepswath, Svetlana L Avlasevich.   

Abstract

In vivo mutation assays based on the Pig-a null phenotype, that is, the absence of cell surface glycosylphosphatidylinositol (GPI) anchored proteins such as CD59, have been described. This work has been accomplished with hematopoietic cells, most often rat peripheral blood erythrocytes (RBCs) and reticulocytes (RETs). The current report describes new sample processing procedures that dramatically increase the rate at which cells can be evaluated for GPI anchor deficiency. This new method was applied to blood specimens from vehicle, 1,3-propane sultone, melphalan, and N-ethyl-N-nitrosourea treated Sprague Dawley rats. Leukocyte- and platelet-depleted blood samples were incubated with anti-CD59-phycoerythrin (PE) and anti-CD61-PE, and then mixed with anti-PE paramagnetic particles and Counting Beads (i.e., fluorescent microspheres). An aliquot of each specimen was stained with SYTO 13 and flow cytometric analysis was performed to determine RET percentage, RET:Counting Bead ratio, and RBC:Counting Bead ratio. The major portion of these specimens were passed through ferromagnetic columns that were suspended in a magnetic field, thereby depleting each specimen of wild-type RBCs (and platelets) based on their association with anti-PE paramagnetic particles. The eluates were concentrated via centrifugation and the resulting suspensions were stained with SYTO 13 and analyzed on the flow cytometer to determine mutant phenotype RET:Counting Bead and mutant phenotype RBC:Counting Bead ratios. The ratios obtained from pre- and post-column analyses were used to derive mutant phenotype RET and mutant phenotype RBC frequencies. Results from vehicle control and genotoxicant-treated rats are presented that indicate the scoring system is capable of returning reliable mutant phenotype cell frequencies. Using this wild-type cell depletion strategy, it was possible to interrogate ≥ 3 million RETs and ≥ 100 million RBCs per rat in approximately 7 min. Beyond considerably enhancing the throughput capacity of the analytical platform, these blood-processing procedures were also shown to enhance the precision of the measurements.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21277384      PMCID: PMC3064711          DOI: 10.1016/j.mrgentox.2011.01.009

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  17 in total

1.  Strategies in case of positive in vivo results in genotoxicity testing.

Authors:  Véronique Thybaud; James T Macgregor; Lutz Müller; Riccardo Crebelli; Kerry Dearfield; George Douglas; Peter B Farmer; Elmar Gocke; Makoto Hayashi; David P Lovell; Werner K Lutz; Daniel Marzin; Martha Moore; Takehiko Nohmi; David H Phillips; Jan Van Benthem
Journal:  Mutat Res       Date:  2010-09-17       Impact factor: 2.433

2.  Quantitative analysis of the expression of glycosylphosphatidylinositol-anchored proteins during the maturation of different hematopoietic cell compartments of normal bone marrow.

Authors:  Pilar María Hernández-Campo; Julia Almeida; Sergio Matarraz; María de Santiago; María Luz Sánchez; Alberto Orfao
Journal:  Cytometry B Clin Cytom       Date:  2007-01-15       Impact factor: 3.058

3.  International Pig-a gene mutation assay trial: evaluation of transferability across 14 laboratories.

Authors:  Stephen D Dertinger; Souk Phonethepswath; Pamela Weller; John Nicolette; Joel Murray; Paul Sonders; Hans-Werner Vohr; Jing Shi; Ljubica Krsmanovic; Carol Gleason; Laura Custer; Andrew Henwood; Kevin Sweder; Leon F Stankowski; Daniel J Roberts; Amanda Giddings; Julia Kenny; Anthony M Lynch; Céline Defrain; Fabrice Nesslany; Bas-jan M van der Leede; Terry Van Doninck; Ann Schuermans; Kentaro Tanaka; Yoshie Hiwata; Osamu Tajima; Eleanor Wilde; Azeddine Elhajouji; William C Gunther; Catherine J Thiffeault; Thomas J Shutsky; Ronald D Fiedler; Takafumi Kimoto; Javed A Bhalli; Robert H Heflich; James T MacGregor
Journal:  Environ Mol Mutagen       Date:  2011-09-11       Impact factor: 3.216

4.  Evaluation of Macaca mulatta as a model for genotoxicity studies.

Authors:  Vasily N Dobrovolsky; Joseph G Shaddock; Roberta A Mittelstaedt; Mugimane G Manjanatha; Daishiro Miura; Makoto Uchikawa; Donald R Mattison; Suzanne M Morris
Journal:  Mutat Res       Date:  2008-11-27       Impact factor: 2.433

5.  In vivo mutation assay based on the endogenous Pig-a locus.

Authors:  Steven M Bryce; Jeffrey C Bemis; Stephen D Dertinger
Journal:  Environ Mol Mutagen       Date:  2008-05       Impact factor: 3.216

6.  Development of an in vivo gene mutation assay using the endogenous Pig-A gene: I. Flow cytometric detection of CD59-negative peripheral red blood cells and CD48-negative spleen T-cells from the rat.

Authors:  Daishiro Miura; Vasily N Dobrovolsky; Yoshinori Kasahara; Yasuhiro Katsuura; Robert H Heflich
Journal:  Environ Mol Mutagen       Date:  2008-10       Impact factor: 3.216

7.  Development of an in vivo gene mutation assay using the endogenous Pig-A gene: II. Selection of Pig-A mutant rat spleen T-cells with proaerolysin and sequencing Pig-A cDNA from the mutants.

Authors:  Daishiro Miura; Vasily N Dobrovolsky; Roberta A Mittelstaedt; Yoshinori Kasahara; Yasuhiro Katsuura; Robert H Heflich
Journal:  Environ Mol Mutagen       Date:  2008-10       Impact factor: 3.216

Review 8.  New and emerging technologies for genetic toxicity testing.

Authors:  Anthony M Lynch; Jennifer C Sasaki; Rosalie Elespuru; David Jacobson-Kram; Véronique Thybaud; Marlies De Boeck; Marilyn J Aardema; Jiri Aubrecht; R Daniel Benz; Stephen D Dertinger; George R Douglas; Paul A White; Patricia A Escobar; Albert Fornace; Masamitsu Honma; Russell T Naven; James F Rusling; Robert H Schiestl; Richard M Walmsley; Eiji Yamamura; Jan van Benthem; James H Kim
Journal:  Environ Mol Mutagen       Date:  2010-08-25       Impact factor: 3.216

9.  Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea.

Authors:  Daishiro Miura; Vasily N Dobrovolsky; Takafumi Kimoto; Yoshinori Kasahara; Robert H Heflich
Journal:  Mutat Res       Date:  2009-06-06       Impact factor: 2.433

10.  Deficient biosynthesis of N-acetylglucosaminyl-phosphatidylinositol, the first intermediate of glycosyl phosphatidylinositol anchor biosynthesis, in cell lines established from patients with paroxysmal nocturnal hemoglobinuria.

Authors:  M Takahashi; J Takeda; S Hirose; R Hyman; N Inoue; T Miyata; E Ueda; T Kitani; M E Medof; T Kinoshita
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  23 in total

1.  Comparison of male versus female responses in the Pig-a mutation assay.

Authors:  Carson Labash; Svetlana L Avlasevich; Kristine Carlson; Dorothea K Torous; Ariel Berg; Jeffrey C Bemis; James T MacGregor; Stephen D Dertinger
Journal:  Mutagenesis       Date:  2015-04-01       Impact factor: 3.000

2.  Integration of Pig-a, micronucleus, chromosome aberration and comet assay endpoints in a 28-day rodent toxicity study with urethane.

Authors:  Leon F Stankowski; Marilyn J Aardema; Timothy E Lawlor; Kamala Pant; Shambhu Roy; Yong Xu; Reem Elbekai
Journal:  Mutagenesis       Date:  2015-05-01       Impact factor: 3.000

3.  Dietary folic acid protects against genotoxicity in the red blood cells of mice.

Authors:  Amanda J MacFarlane; Nathalie A Behan; Martha S Field; Andrew Williams; Patrick J Stover; Carole L Yauk
Journal:  Mutat Res       Date:  2015-06-29       Impact factor: 2.433

4.  Comparison of in vitro and in vivo clastogenic potency based on benchmark dose analysis of flow cytometric micronucleus data.

Authors:  Jeffrey C Bemis; John W Wills; Steven M Bryce; Dorothea K Torous; Stephen D Dertinger; Wout Slob
Journal:  Mutagenesis       Date:  2015-06-06       Impact factor: 3.000

5.  Pig-a gene mutation assay study design: critical assessment of 3- versus 28-day repeat-dose treatment schedules.

Authors:  Azeddine Elhajouji; Tamsanqa Tafara Hove; Oliver O'Connell; Hansjoerg Martus; Stephen D Dertinger
Journal:  Mutagenesis       Date:  2020-09-12       Impact factor: 3.000

6.  Defining EMS and ENU dose-response relationships using the Pig-a mutation assay in rats.

Authors:  Krista L Dobo; Ronald D Fiedler; William C Gunther; Catherine J Thiffeault; Zoryana Cammerer; Stephanie L Coffing; Thomas Shutsky; Maik Schuler
Journal:  Mutat Res       Date:  2011-06-24       Impact factor: 2.433

7.  Diet-induced obesity increases the frequency of Pig-a mutant erythrocytes in male C57BL/6J mice.

Authors:  Jeffrey K Wickliffe; Stephen D Dertinger; Dorothea K Torous; Svetlana L Avlasevich; Bridget R Simon-Friedt; Mark J Wilson
Journal:  Environ Mol Mutagen       Date:  2016-10-14       Impact factor: 3.216

8.  In vivo pig-a and micronucleus study of the prototypical aneugen vinblastine sulfate.

Authors:  Svetlana L Avlasevich; Carson Labash; Dorothea K Torous; Jeffrey C Bemis; James T MacGregor; Stephen D Dertinger
Journal:  Environ Mol Mutagen       Date:  2017-08-19       Impact factor: 3.216

9.  Integration of liver and blood micronucleus and Pig-a gene mutation endpoints into rat 28-day repeat-treatment studies: Proof-of-principle with diethylnitrosamine.

Authors:  Sumee Khanal; Priyanka Singh; Svetlana L Avlasevich; Dorothea K Torous; Jeffrey C Bemis; Stephen D Dertinger
Journal:  Mutat Res Genet Toxicol Environ Mutagen       Date:  2018-02-23       Impact factor: 2.873

10.  Sensitivity of the Pig-a assay for detecting gene mutation in rats exposed acutely to strong clastogens.

Authors:  Javed A Bhalli; Joseph G Shaddock; Mason G Pearce; Vasily N Dobrovolsky
Journal:  Mutagenesis       Date:  2013-05-15       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.